Stockpolly
Search
LUNG · NASDAQ · Medical - Devices

Pulmonx (LUNG)

Builds bronchoscopic emphysema treatments around Zephyr valves and patient-selection tools.

$2.05
Pre-market−0.24 (−10.47%)
At close$2.29(+2.23%)
Watchlist

In millions of USD, except per-share figures

In millionsQ3 FY23Sep 2023Q4 FY23Dec 2023Q1 FY24Mar 2024Q2 FY24Jun 2024Q3 FY24Sep 2024Q4 FY24Dec 2024Q1 FY25Mar 2025Q2 FY25Jun 2025Q3 FY25Sep 2025Q4 FY25Dec 2025Q1 FY26Mar 2026Q2 FY26Jun 2026
Revenue181919212024232422232123
Cost of revenue555556675555
Gross profit131414151518161716181618
282829312931313230272927
Research & development444644555555
242424252527262726232422
Selling & marketing050008000000
General & administrative02000019000000
Operating income−15−14−15−16−14−13−15−15−14−10−13−9
0010000010−1−1
Interest income121111111000
Interest expense111111111111
Other non-operating income−1−1−2−1−1−11−1−1000
Income before tax−15−14−14−15−14−13−14−15−14−10−14−10
Income tax expense000000000000
Net income from continuing operations−15−14−14−15−14−13−14−15−14−10−14−10
Net income−15−14−14−15−14−13−14−15−14−10−14−10
EPS, basic−$0.39−$0.36−$0.36−$0.39−$0.36−$0.33−$0.36−$0.38−$0.34−$0.25−$0.33−$0.23
EPS, diluted−$0.39−$0.36−$0.36−$0.39−$0.36−$0.33−$0.36−$0.38−$0.34−$0.25−$0.33−$0.23
Weighted average shares, basic383839393939404041414242
Weighted average shares, diluted383839393939404041414242
EBITDA−14−12−12−14−13−12−15−14−13−9−12−9
Depreciation & amortization001000100000
EBIT−14−13−13−14−13−12−15−14−13−9−13−9